Drug:
Reaction: DRUG INTERACTION
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26512641 |
EU |
73 | 2 |
Status epilepticus, Drug interaction, |
||||
LANSOPRAZOLE, OXYCODONE, KETOPROFEN, GABAPENTIN, |
||||
| 202 | 26512689 |
US |
1 | |
Drug interaction, |
||||
ROSUVASTATIN, TAFAMIDIS, |
||||
| 203 | 26512754 |
US |
10 | 1 |
Drug level increased, Altered state of consciousness, Somnolence, Drug interaction, |
||||
VALPROIC ACID, FAMOTIDINE, |
||||
| 204 | 26512947 |
EU |
46 | |
Hepatotoxicity, Drug interaction, Blood bilirubin increased, Gamma-glutamyltransferase increased, Blood alkaline phosphatase increased, Hypertransaminasaemia, |
||||
DENOSUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MELATONIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CEFADROXIL, DALFAMPRIDINE, CALCIFEDIOL, CALCIUM, TIZANIDINE, OCRELIZUMAB, |
||||
| 205 | 26513681 |
GB |
78 | 1 |
Drug interaction, Deep vein thrombosis, |
||||
APIXABAN, PRIMIDONE, |
||||
| 206 | 26513820 |
EU |
86 | 1 |
Depressed level of consciousness, Drug interaction, |
||||
ERTAPENEM, ERTAPENEM SODIUM, FENTANYL, |
||||
| 207 | 26514151 |
EU |
40 | 1 |
Toxicity to various agents, Arrhythmia, Seizure, Respiratory depression, Drug interaction, Drug abuse, Cardiac arrest, Cardiopulmonary failure, |
||||
| 208 | 26514227 |
US |
62 | 2 |
Acute hepatic failure, Multiple organ dysfunction syndrome, Atrial fibrillation, Acute kidney injury, Lactic acidosis, Liver injury, Shock, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DULAGLUTIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GLIPIZIDE, GLIPIZIDE-TABLETS, HYDROXYZINE, ZOLPIDEM TARTRATE, |
||||
| 209 | 26515001 |
EU |
60 | 1 |
Cardiac disorder, Diabetes mellitus, Carotid arteriosclerosis, Diabetic metabolic decompensation, Listless, Disturbance in attention, Drug interaction, Pain in extremity, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Peripheral arterial occlusive disease, Peripheral arterial occlusive disease, |
||||
PANTOPRAZOLE, PANTOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, BISOPROLOL FUMARATE, VALSARTAN, VALSARTAN ORAL, SIMVASTATIN, SIMVASTATIN, EZETIMIBE, INSULIN DEGLUDEC, LIRAGLUTIDE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, INSULIN GLARGINE, ERGOCALCIFEROL, PRASUGREL, |
||||
| 210 | 26515425 |
US |
87 | 1 |
Thrombocytopenia, Drug interaction, Drug clearance decreased, Off label use, Stomatitis, Epistaxis, Anaemia, Fatigue, Malaise, |
||||
METHOTREXATE SODIUM, FUROSEMIDE, |
||||
| 211 | 26515434 |
US |
1 | |
Constipation, Blood potassium decreased, Muscle spasms, Drug interaction, |
||||
ROSUVASTATIN, TAFAMIDIS, |
||||
| 212 | 26515493 |
US |
7 | 2 |
Drug interaction, |
||||
FLUCONAZOLE, |
||||
| 213 | 26515629 |
EU |
||
Drug interaction, Haemoptysis, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, BISOPROLOL FUMARATE, EZETIMIBE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SIMVASTATIN, |
||||
| 214 | 26515638 |
EU |
||
Drug interaction, Urinary retention, Somnolence, Wrong patient received product, |
||||
OLANZAPINE, QUETIAPINE, OXAZEPAM, VALPROATE SODIUM, CLOBAZAM, ATROPINE SULFATE, ATROPINE, |
||||
| 215 | 26516009 |
EU |
52 | 2 |
Hepatotoxicity, Hypertransaminasaemia, Blood bilirubin increased, Gamma-glutamyltransferase increased, Blood alkaline phosphatase increased, Drug interaction, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MELATONIN, MELATONIN, MELATONIN, MELATONIN, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, DALFAMPRIDINE, DALFAMPRIDINE, DALFAMPRIDINE, DALFAMPRIDINE, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, |
||||
| 216 | 26516277 |
JP |
68 | 2 |
Drug interaction, Cardioactive drug level increased, Hypotension, |
||||
NIFEDIPINE, NIFEDIPINE, TELMISARTAN, BISOPROLOL FUMARATE, DAPAGLIFLOZIN, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SEMAGLUTIDE, INSULIN DEGLUDEC, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ALPROSTADIL, |
||||
| 217 | 26516654 |
AU |
35 | 2 |
Drug interaction, Toxicity to various agents, |
||||
MORPHINE SULFATE, ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 218 | 26516707 |
CA |
37 | 2 |
Drug interaction, Respiratory depression, Somnolence, |
||||
CLOZAPINE, |
||||
| 219 | 26507665 |
US |
1 | |
Cerebral haemorrhage, Fall, Drug interaction, |
||||
FOSCARBIDOPA/FOSLEVODOPA, RIVASTIGMINE TARTRATE, OXYBUTYNIN, VIBEGRON, PIMAVANSERIN TARTRATE, MIRTAZAPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, POLYETHYLENE GLYCOL 3350, VITAMIN C, ERGOCALCIFEROL, |
||||
| 220 | 26507698 |
AU |
33 | 2 |
Serotonin syndrome, Vision blurred, Condition aggravated, Drug interaction, Irritability, Abdominal pain upper, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 221 | 26507704 |
CA |
58 | 2 |
Abdominal discomfort, Back injury, Benign abdominal neoplasm, Benign ovarian tumour, Blood pressure diastolic abnormal, Blood pressure increased, Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Body temperature decreased, Chills, Drug hypersensitivity, Fungal infection, Gait disturbance, Human papilloma virus test positive, Impaired healing, Infection, Influenza, Lip injury, Lower respiratory tract congestion, Migraine, Musculoskeletal stiffness, Nasopharyngitis, Oral herpes, Oral herpes, Oral herpes, Oral herpes, Oral pain, Oropharyngeal pain, Ovarian cyst, Oxygen saturation decreased, Pneumonia, Productive cough, Rheumatoid arthritis, Rhinorrhoea, Skin fissures, Sneezing, Stomatitis, Stomatitis, Tinnitus, Ulcer, Upper respiratory tract infection, Drug interaction, Back pain, Malaise, Gastrooesophageal reflux disease, Cough, Hepatic enzyme increased, Infusion related reaction, Nausea, Nausea, Pain, Paraesthesia, Weight decreased, Weight increased, Arthralgia, Drug ineffective, |
||||
PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, |
||||
| 222 | 26507754 |
EU |
51 | 2 |
Persistent genital arousal disorder, Drug interaction, |
||||
MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, PREGABALIN, |
||||
| 223 | 26507867 |
EU |
46 | 2 |
Drug interaction, Hepatotoxicity, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MELATONIN, OCRELIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CEFADROXIL, DALFAMPRIDINE, DENOSUMAB, CALCIFEDIOL, CALCIUM, TIZANIDINE, |
||||
| 224 | 26507959 |
EU |
51 | 1 |
Seizure, Drug interaction, |
||||
VALPROIC ACID, ERTAPENEM, ERTAPENEM SODIUM, FLUCONAZOLE, BACLOFEN, GABAPENTIN, SACCHAROMYCES CEREVISIAE, ENOXAPARIN SODIUM, |
||||
| 225 | 26507987 |
IN |
25 | 2 |
Peripheral vascular disorder, Drug interaction, Ergot poisoning, Off label use, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, GABAPENTIN, |
||||
| 226 | 26507995 |
GB |
78 | 1 |
Drug interaction, |
||||
APIXABAN, PRIMIDONE, |
||||
| 227 | 26508046 |
US |
62 | 2 |
Renal disorder, Drug interaction, Toxicity to various agents, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 228 | 26508088 |
EU |
51 | 2 |
Persistent genital arousal disorder, Drug interaction, Product use in unapproved indication, |
||||
TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, PREGABALIN, PREGABALIN, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 229 | 26508191 |
EU |
60 | 1 |
Cardiac disorder, Diabetic metabolic decompensation, Carotid arteriosclerosis, Diabetes mellitus, Listless, Disturbance in attention, Drug interaction, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Peripheral arterial occlusive disease, Peripheral arterial occlusive disease, Pain in extremity, |
||||
EZETIMIBE, AMLODIPINE BESYLATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE, PANTOPRAZOLE, BISOPROLOL FUMARATE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, SIMVASTATIN, SIMVASTATIN, INSULIN DEGLUDEC, LIRAGLUTIDE, ERGOCALCIFEROL, HYDROCHLOROTHIAZIDE, PRASUGREL, ROSUVASTATIN, |
||||
| 230 | 26508661 |
US |
62 | 2 |
Lactic acidosis, Shock, Acute kidney injury, Liver injury, Acute hepatic failure, Atrial fibrillation, Multiple organ dysfunction syndrome, Drug interaction, Toxicity to various agents, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 231 | 26508667 |
US |
23 | 2 |
Serotonin syndrome, Drug interaction, |
||||
ISONIAZID, LITHIUM, LITHIUM BROMATUM, VALPROIC ACID, OXYCODONE, OXYCODONE, DEXMEDETOMIDINE, PROPOFOL, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, OLANZAPINE, LORAZEPAM, HALOPERIDOL, HALOPERIDOL LACTATE, PREGABALIN, PREGABALIN, |
||||
| 232 | 26508722 |
EU |
1 | |
Drug interaction, Therapeutic agent-diagnostic test interaction, Drug ineffective, Nephropathy toxic, Exposure to radiation, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, TECHNETIUM TC-99M, |
||||
| 233 | 26508725 |
EU |
62 | 1 |
Urinary retention, Somnolence, Drug interaction, Wrong patient received product, |
||||
OLANZAPINE, QUETIAPINE, ATROPINE SULFATE, ATROPINE, VALPROATE SODIUM, OXAZEPAM, CLOBAZAM, |
||||
| 234 | 26509427 |
GB |
||
Hallucination, Medication error, Glossodynia, Dyspnoea, Dysgeusia, Drug interaction, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ACETYLCYSTEINE, APIXABAN, DIGOXIN, FLUCONAZOLE, FUROSEMIDE, LANSOPRAZOLE, LOSARTAN, MIRTAZAPINE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, |
||||
| 235 | 26509428 |
EU |
40 | 1 |
Fall, Hypotension, Drug interaction, Somnolence, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 236 | 26509976 |
EU |
62 | 1 |
Urinary retention, Somnolence, Drug interaction, Wrong patient received product, |
||||
OLANZAPINE, QUETIAPINE, OXAZEPAM, VALPROATE SODIUM, CLOBAZAM, ATROPINE SULFATE, ATROPINE, |
||||
| 237 | 26509999 |
EU |
68 | 1 |
Depressed level of consciousness, Wrong patient, Wrong drug, Wrong dose, Drug interaction, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 238 | 26510027 |
US |
78 | 2 |
Cerebrovascular accident, Disease progression, Drug interaction, |
||||
OSIMERTINIB, OSIMERTINIB, SELPERCATINIB, |
||||
| 239 | 26510189 |
EU |
86 | 1 |
Depressed level of consciousness, Drug interaction, |
||||
FENTANYL, FENTANYL, FENTANYL, FENTANYL, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, |
||||
| 240 | 26510619 |
GB |
65 | 2 |
Drug interaction, |
||||
CARBAMAZEPINE, AMLODIPINE, LOSARTAN, |
||||
| 241 | 26511028 |
EU |
2 | |
Hyperbilirubinaemia, Drug interaction, |
||||
CYCLOSPORINE, CYCLOSPORINE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ACYCLOVIR, ANTI-THYMOCYTE GLOBULIN (RABBIT), |
||||
| 242 | 26511377 |
GB |
65 | 2 |
Drug interaction, Hypertension, |
||||
LOSARTAN, AMLODIPINE, CARBAMAZEPINE, ATENOLOL, SPIRONOLACTONE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 243 | 26511406 |
AU |
||
Serotonin syndrome, Drug interaction, Maternal exposure during pregnancy, Nausea, Product prescribing issue, Vomiting, Anxiety, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), BENZTROPINE, MIRTAZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM OXALATE, ESCITALOPRAM, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 244 | 26511514 |
EU |
60 | 1 |
Cardiac disorder, Diabetes mellitus, Diabetic metabolic decompensation, Carotid arteriosclerosis, Listless, Disturbance in attention, Drug interaction, Pain in extremity, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Peripheral arterial occlusive disease, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, PRASUGREL, PRASUGREL, PRASUGREL, PRASUGREL, |
||||
| 245 | 26511610 |
PR |
41 | 2 |
Cushing^s syndrome, Adrenal insufficiency, Drug interaction, |
||||
AMLODIPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 246 | 26511660 |
EU |
60 | 1 |
Cardiac disorder, Diabetes mellitus, Diabetic metabolic decompensation, Listless, Disturbance in attention, Drug interaction, Pain in extremity, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Carotid arteriosclerosis, Peripheral arterial occlusive disease, Peripheral arterial occlusive disease, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, VALSARTAN, VALSARTAN ORAL, BISOPROLOL FUMARATE, EZETIMIBE, AMLODIPINE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SIMVASTATIN, SIMVASTATIN, PANTOPRAZOLE, PANTOPRAZOLE, INSULIN DEGLUDEC, LIRAGLUTIDE, ROSUVASTATIN, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, PRASUGREL, |
||||
| 247 | 26511902 |
AU |
29 | 2 |
Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 248 | 26511903 |
AU |
26 | 1 |
Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, |
||||
| 249 | 26511906 |
AU |
36 | 2 |
Brain hypoxia, Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, |
||||
| 250 | 26511908 |
AU |
32 | 1 |
Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, ALPRAZOLAM, |
||||
| 251 | 26511909 |
AU |
38 | 1 |
Drug interaction, Overdose, |
||||
MORPHINE SULFATE, MIRTAZAPINE, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, |
||||
| 252 | 26511912 |
EU |
2 | |
Death, Insomnia, Somnolence, Weight increased, Oedema peripheral, Drug interaction, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, PREGABALIN, MORPHINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FUROSEMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, GABAPENTIN, GABAPENTIN, |
||||
| 253 | 26511913 |
AU |
29 | 2 |
Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, ALCOHOL, ISOPROPYL ALCOHOL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), MIRTAZAPINE, |
||||
| 254 | 26511914 |
AU |
54 | 1 |
Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, |
||||
| 255 | 26511915 |
AU |
25 | 1 |
Toxicity to various agents, Drug interaction, |
||||
MORPHINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 256 | 26512095 |
MX |
2 | |
Malignant melanoma, Drug interaction, Neoplasm, |
||||
UPADACITINIB, |
||||
| 257 | 26502913 |
US |
62 | 2 |
Lactic acidosis, Toxicity to various agents, Multiple organ dysfunction syndrome, Drug interaction, Shock, Metabolic acidosis, Acute kidney injury, Liver injury, Atrial fibrillation, Acute hepatic failure, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, GLIPIZIDE, GLIPIZIDE-TABLETS, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HYDROXYZINE, DULAGLUTIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ZOLPIDEM TARTRATE, |
||||
| 258 | 26503124 |
US |
44 | 2 |
Tardive dyskinesia, Gait disturbance, Fall, Dizziness, Drug interaction, Off label use, |
||||
MIRABEGRON, CLOZAPINE, PALIPERIDONE, |
||||
| 259 | 26503143 |
EU |
74 | 1 |
Drug interaction, Constipation, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, RAMIPRIL, |
||||
| 260 | 26503346 |
EU |
73 | 1 |
Gastrointestinal haemorrhage, Herbal interaction, Drug interaction, |
||||
LENALIDOMIDE, |
||||
| 261 | 26503483 |
US |
2 | |
Nasal congestion, Drug hypersensitivity, Drug interaction, |
||||
METOPROLOL TARTRATE, METOPROLOL, DUPILUMAB, |
||||
| 262 | 26503571 |
EU |
60 | 1 |
Cardiac disorder, Diabetes mellitus, Diabetic metabolic decompensation, Listless, Disturbance in attention, Drug interaction, Pain in extremity, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Carotid arteriosclerosis, Peripheral arterial occlusive disease, Peripheral arterial occlusive disease, |
||||
AMLODIPINE, VALSARTAN, VALSARTAN ORAL, BISOPROLOL FUMARATE, SIMVASTATIN, SIMVASTATIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EZETIMIBE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INSULIN DEGLUDEC, LIRAGLUTIDE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, INSULIN GLARGINE, ERGOCALCIFEROL, PRASUGREL, |
||||
| 263 | 26503685 |
IN |
41 | 1 |
Delirium, Drug interaction, |
||||
OLANZAPINE, OLANZAPINE, DIVALPROEX SODIUM, DIVALPROEX SODIUM, CLONAZEPAM, |
||||
| 264 | 26503718 |
IN |
26 | 2 |
Neuromuscular blockade, Delayed recovery from anaesthesia, Drug interaction, |
||||
HYDROXYCHLOROQUINE, PROPOFOL, FENTANYL, OXYGEN, 0XYGEN, SEVOFLURANE, |
||||
| 265 | 26503860 |
62 | ||
Atrial fibrillation, Multiple organ dysfunction syndrome, Shock, Acute kidney injury, Liver injury, Metabolic acidosis, Toxicity to various agents, Drug interaction, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 266 | 26503907 |
CH |
18 | 2 |
Movement disorder, Drug ineffective, Anaphylactic reaction, Drug level increased, Drug interaction, Tachycardia, Muscle disorder, |
||||
RISPERIDONE, RISPERIDONE, CLONIDINE, QUETIAPINE, CHLORPROMAZINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, GABAPENTIN, LORAZEPAM, PROPRANOLOL HYDROCHLORIDE, LITHIUM, LITHIUM BROMATUM, VITAMIN C, |
||||
| 267 | 26503976 |
EU |
40 | 1 |
Fall, Hypotension, Drug interaction, Somnolence, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 268 | 26504027 |
EU |
52 | 2 |
Hepatotoxicity, Hypertransaminasaemia, Drug interaction, Blood bilirubin increased, Gamma-glutamyltransferase increased, Blood alkaline phosphatase increased, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MELATONIN, SERTRALINE, OCRELIZUMAB, DALFAMPRIDINE, BACLOFEN, |
||||
| 269 | 26504139 |
62 | ||
Lactic acidosis, Shock, Acute kidney injury, Liver injury, Atrial fibrillation, Acute hepatic failure, Multiple organ dysfunction syndrome, Toxicity to various agents, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 270 | 26504165 |
EU |
46 | 2 |
Hepatotoxicity, Drug interaction, Blood bilirubin increased, Gamma-glutamyltransferase increased, Blood alkaline phosphatase increased, Hypertransaminasaemia, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MELATONIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SERTRALINE, OCRELIZUMAB, CEFADROXIL, DALFAMPRIDINE, DENOSUMAB, CALCIFEDIOL, CALCIFEDIOL, CALCIUM, TIZANIDINE, BACLOFEN, VITAMIN E, |
||||
| 271 | 26504189 |
US |
28 | 1 |
Drug intolerance, Drug level above therapeutic, Drug interaction, Vomiting, |
||||
FLUCONAZOLE, AMPHOTERICIN B, COLCHICINE, |
||||
| 272 | 26504197 |
EU |
57 | 1 |
Drug interaction, Haemoptysis, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, AMLODIPINE, BISOPROLOL FUMARATE, EZETIMIBE, SIMVASTATIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 273 | 26504236 |
GB |
37 | 1 |
Medication error, Drug interaction, |
||||
CLARITHROMYCIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 274 | 26504272 |
GB |
78 | 1 |
Deep vein thrombosis, Drug interaction, |
||||
APIXABAN, PRIMIDONE, |
||||
| 275 | 26504344 |
US |
32 | 2 |
Cholestatic liver injury, Hypothyroidism, Wrong technique in product usage process, Therapeutic response decreased, Drug interaction, |
||||
CHOLESTYRAMINE, DAPAGLIFLOZIN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, PANTOPRAZOLE, TIRZEPATIDE, CHOLESTYRAMINE, |
||||
| 276 | 26504404 |
US |
62 | 2 |
Shock, Acute kidney injury, Liver injury, Acute hepatic failure, Atrial fibrillation, Multiple organ dysfunction syndrome, Drug interaction, Toxicity to various agents, Lactic acidosis, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 277 | 26504413 |
US |
19 | 2 |
Electrocardiogram QT prolonged, Cardiac arrest, Torsade de pointes, Drug interaction, |
||||
HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 278 | 26504446 |
EU |
81 | 1 |
Acute kidney injury, Drug interaction, |
||||
FUROSEMIDE, DAPAGLIFLOZIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, SEMAGLUTIDE, ORAL SEMAGLUTIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ENTECAVIR, ENTECAVIR ANHYDROUS, CLOPIDOGREL, CLOPIDOGREL BISULFATE, INSULIN DETEMIR, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LANSOPRAZOLE, EZETIMIBE, |
||||
| 279 | 26504548 |
IN |
41 | 1 |
Delirium, Drug interaction, |
||||
CLONAZEPAM, OLANZAPINE, VALPROATE SODIUM, VALPROATE SODIUM, OLANZAPINE, |
||||
| 280 | 26504558 |
US |
49 | 1 |
Oculogyric crisis, Drug interaction, Off label use, |
||||
AMANTADINE, SUGAMMADEX, LORAZEPAM, LORAZEPAM, DEXMEDETOMIDINE, ROCURONIUM, ROCURONIUM BROMIDE, |
||||
| 281 | 26504594 |
CA |
||
Neoplasm malignant, Viral load increased, Weight increased, Drug interaction, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 282 | 26504598 |
GB |
37 | 1 |
Drug interaction, Medication error, |
||||
CLARITHROMYCIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 283 | 26505135 |
US |
67 | 1 |
Leukopenia, Anaemia, Drug interaction, Insomnia, Myalgia, Protein total decreased, Muscle spasms, Product dose omission issue, |
||||
PRAVASTATIN SODIUM, ROSUVASTATIN CALCIUM, RELUGOLIX, DAROLUTAMIDE, |
||||
| 284 | 26505156 |
EU |
51 | 1 |
Seizure, Drug interaction, |
||||
VALPROIC ACID, FLUCONAZOLE, ERTAPENEM, ERTAPENEM SODIUM, BACLOFEN, GABAPENTIN, SACCHAROMYCES CEREVISIAE, ENOXAPARIN SODIUM, |
||||
| 285 | 26505406 |
GE |
28 | 2 |
Ischaemic stroke, Drug interaction, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 286 | 26505433 |
GB |
65 | 2 |
Hypertension, Drug interaction, |
||||
CARBAMAZEPINE, AMLODIPINE, ATENOLOL, DOXAZOSIN, DOXAZOSIN MESYLATE, LOSARTAN, OXCARBAZEPINE, SPIRONOLACTONE, |
||||
| 287 | 26505859 |
EU |
60 | 1 |
Cardiac disorder, Diabetes mellitus, Diabetic metabolic decompensation, Listless, Disturbance in attention, Drug interaction, Pain in extremity, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Carotid arteriosclerosis, Peripheral arterial occlusive disease, Peripheral arterial occlusive disease, |
||||
INSULIN DEGLUDEC, LIRAGLUTIDE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, BISOPROLOL FUMARATE, VALSARTAN, VALSARTAN ORAL, SIMVASTATIN, SIMVASTATIN, EZETIMIBE, PANTOPRAZOLE, PANTOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, INSULIN GLARGINE, ERGOCALCIFEROL, PRASUGREL HYDROCHLORIDE, |
||||
| 288 | 26505918 |
IN |
48 | 2 |
Drug interaction, Hallucination, Psychotic disorder, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, MODAFINIL, MODAFINIL, MODAFINIL, MODAFINIL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CLONAZEPAM, |
||||
| 289 | 26506118 |
JP |
64 | |
Drug interaction, Pneumonia, |
||||
RUXOLITINIB, FAMOTIDINE, FAMOTIDINE, VONOPRAZAN FUMARATE, VONOPRAZAN FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MAGNESIUM OXIDE, URSODIOL, URSOSIOL, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, FUROSEMIDE, ACYCLOVIR, VALSARTAN, VALSARTAN ORAL, |
||||
| 290 | 26506920 |
EU |
52 | 2 |
Hypertransaminasaemia, Hepatotoxicity, Drug interaction, |
||||
SERTRALINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MELATONIN, OCRELIZUMAB, DALFAMPRIDINE, BACLOFEN, |
||||
| 291 | 26507056 |
GB |
||
Off label use, Crying, Apathy, Fatigue, Balance disorder, Self-injurious ideation, Suicidal ideation, Depressed mood, Drug interaction, |
||||
CENOBAMATE, CENOBAMATE, LACOSAMIDE, CLOBAZAM, |
||||
| 292 | 26507083 |
EU |
54 | 2 |
Drug interaction, Anaphylactic shock, |
||||
TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PERTUZUMAB, |
||||
| 293 | 26497916 |
GB |
||
Hypertension, Drug interaction, |
||||
LOSARTAN, AMLODIPINE, CARBAMAZEPINE, ATENOLOL, SPIRONOLACTONE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 294 | 26497925 |
GB |
||
Drug interaction, Deep vein thrombosis, |
||||
APIXABAN, PRIMIDONE, |
||||
| 295 | 26497943 |
US |
||
Lactic acidosis, Shock, Acute kidney injury, Liver injury, Acute hepatic failure, Atrial fibrillation, Multiple organ dysfunction syndrome, Toxicity to various agents, Drug interaction, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 296 | 26498165 |
IN |
42 | 2 |
Drug-genetic interaction, Drug interaction, Bruxism, Dry mouth, Eye irritation, |
||||
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, CLONAZEPAM, |
||||
| 297 | 26498373 |
EU |
85 | 2 |
Dementia, Fall, Fracture, Depression, Cognitive disorder, Drug interaction, |
||||
ALPRAZOLAM, VORTIOXETINE, MIRABEGRON, PRASTERONE, |
||||
| 298 | 26498691 |
US |
62 | 2 |
Toxicity to various agents, Acute kidney injury, Shock, Multiple organ dysfunction syndrome, Atrial fibrillation, Acute hepatic failure, Drug interaction, Liver injury, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, GLIPIZIDE-TABLETS, DULAGLUTIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ZOLPIDEM TARTRATE, HYDROXYZINE, |
||||
| 299 | 26498940 |
EU |
57 | 2 |
Hepatotoxicity, Hypertransaminasaemia, Drug interaction, |
||||
MELATONIN, DALFAMPRIDINE, OCRELIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 300 | 26499419 |
IN |
17 | 1 |
Lymphoid tissue hyperplasia, Hepatosplenomegaly, Drug interaction, Drug reaction with eosinophilia and systemic symptoms, Hepatic enzyme increased, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, VALPROATE SODIUM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, ZONISAMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
